Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 2
1997 1
1999 1
2000 1
2001 1
2002 4
2003 4
2004 8
2005 7
2006 4
2007 10
2008 14
2009 11
2010 12
2011 16
2012 27
2013 22
2014 23
2015 22
2016 21
2017 28
2018 16
2019 26
2020 17
2021 17
2022 21
2023 16
2024 13
2025 20
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Lu JC, Wu LL, Sun YN, Huang XY, Gao C, Guo XJ, Zeng HY, Qu XD, Chen Y, Wu D, Pei YZ, Meng XL, Zheng YM, Liang C, Zhang PF, Cai JB, Ding ZB, Yang GH, Ren N, Huang C, Wang XY, Gao Q, Sun QM, Shi YH, Qiu SJ, Ke AW, Shi GM, Zhou J, Sun YD, Fan J. Lu JC, et al. Among authors: meng xl. Nat Commun. 2024 Jan 20;15(1):621. doi: 10.1038/s41467-024-44795-1. Nat Commun. 2024. PMID: 38245530 Free PMC article.
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Shi GM, Huang XY, Wu D, Sun HC, Liang F, Ji Y, Chen Y, Yang GH, Lu JC, Meng XL, Wang XY, Sun L, Ge NL, Huang XW, Qiu SJ, Yang XR, Gao Q, He YF, Xu Y, Sun J, Ren ZG, Fan J, Zhou J. Shi GM, et al. Among authors: meng xl. Signal Transduct Target Ther. 2023 Mar 17;8(1):106. doi: 10.1038/s41392-023-01317-7. Signal Transduct Target Ther. 2023. PMID: 36928584 Free PMC article. Clinical Trial.
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors.
Zhang DH, Liang C, Hu SY, Huang XY, Yu L, Meng XL, Guo XJ, Zeng HY, Chen Z, Zhang L, Pei YZ, Ye M, Cai JB, Huang PX, Shi YH, Ke AW, Chen Y, Ji Y, Shi YG, Zhou J, Fan J, Yang GH, Sun QM, Shi GM, Lu JC. Zhang DH, et al. Among authors: meng xl. J Transl Med. 2024 Oct 1;22(1):883. doi: 10.1186/s12967-024-05670-1. J Transl Med. 2024. PMID: 39354613 Free PMC article.
Ten Simple Rules for Effective Statistical Practice.
Kass RE, Caffo BS, Davidian M, Meng XL, Yu B, Reid N. Kass RE, et al. Among authors: meng xl. PLoS Comput Biol. 2016 Jun 9;12(6):e1004961. doi: 10.1371/journal.pcbi.1004961. eCollection 2016 Jun. PLoS Comput Biol. 2016. PMID: 27281180 Free PMC article. No abstract available.
A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study.
Tian XP, Xie D, Huang WJ, Ma SY, Wang L, Liu YH, Zhang X, Huang HQ, Lin TY, Rao HL, Li M, Liu F, Zhang F, Zhong LY, Liang L, Lan XL, Li J, Liao B, Li ZH, Tang QL, Liang Q, Shao CK, Zhai QL, Cheng RF, Sun Q, Ru K, Gu X, Lin XN, Yi K, Shuang YR, Chen XD, Dong W, Sang W, Sun C, Liu H, Zhu ZG, Rao J, Guo QN, Zhou Y, Meng XL, Zhu Y, Hu CL, Jiang YR, Zhang Y, Gao HY, He WJ, Xia ZJ, Pan XY, Lan H, Li GW, Liu L, Bao HZ, Song LY, Kang TB, Cai QQ. Tian XP, et al. Among authors: meng xl. Leukemia. 2020 Sep;34(9):2392-2404. doi: 10.1038/s41375-020-0757-5. Epub 2020 Feb 20. Leukemia. 2020. PMID: 32080345
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study.
Huang XY, Shi GM, Zheng ZT, Sun HC, Liang F, Ji Y, Chen Y, Yang GH, Hu ZQ, Lu JC, Meng XL, Guo XJ, Zhang CC, Fan J, Zhou J. Huang XY, et al. Among authors: meng xl. BMC Med. 2025 Oct 21;23(1):573. doi: 10.1186/s12916-025-04404-4. BMC Med. 2025. PMID: 41121202 Free PMC article. Clinical Trial.
355 results